Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Back to Industry News
Medtech

Organon CEO Kevin Ali Resigns After Contraceptive Sales Probe

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Reuters
TL;DR

Organon's CEO, Kevin Ali, is stepping down after an internal investigation uncovered improper sales practices involving Nexplanon, where personnel allegedly urged U.S. wholesalers to buy excessive amounts to meet revenue targets. The Head of U.S. Commercial & Government Affairs was also terminated, and Ali forfeited severance and retirement benefits, with Joseph Morrissey appointed as interim CEO.

Key takeaways

  • Organon CEO Kevin Ali is resigning following an internal investigation into improper sales practices related to the Nexplanon contraceptive implant, the company announced Monday
  • The investigation revealed that Organon personnel requested certain U
  • wholesalers to purchase excessive amounts of Nexplanon at the end of multiple quarters, allegedly to meet revenue forecasts and external expectations
Organon CEO Kevin Ali is resigning following an internal investigation into improper sales practices related to the Nexplanon contraceptive implant, the company announced Monday. The investigation revealed that Organon personnel requested certain U.S. wholesalers to purchase excessive amounts of Nexplanon at the end of multiple quarters, allegedly to meet revenue forecasts and external expectations. As a result of the investigation, Organon also terminated its Head of U.S. Commercial & Government Affairs. In connection with his resignation, Ali has forfeited his entitlement to severance and equity-related retirement benefits. Joseph Morrissey, currently Executive Vice President and Head of Manufacturing and Supply, will serve as interim CEO.

Related Topics

OrganonKevin AliresignationNexplanoncontraceptivesales practicesinvestigation

Verified mention available

Free to claim

Is this your company?

Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.

Set up alerts Takes under 1 minute • Verified manually

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original